Delivery Order SPE2DB20D2104-SPE2DB25FMRYD
Award Date
5/28/25
Potential Completion Date
5/29/25
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,123.89 firm fixed-price delivery order is for the pharmaceutical product ZORTRESS 0.5 MG TABLET UD 60S, with a period of performance through July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4556351812 - ZORTRESS 0.5 MG TABLET UD 60S. The contract, valued at $14,738.90, was awarded on February 23, 2022, with a completion date of February 24, 2022. The contract is a Delivery Order under a Firm Fixed Price arrangement. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,184.09 Firm Fixed Price Delivery Order contract is for the supply of ZORTRESS 1 MG TABLET UD 60S, a pharmaceutical product. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,005.00, is for the delivery of the pharmaceutical product ZORTRESS 0.5 MG TABLET UD 60S. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, and has a firm fixed price and an ultimate completion date of June 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FU27E, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,888.97 firm-fixed-price delivery order is for the supply of the medication ZORTRESS 0.5 MG TABLET UD 60S. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,263.31, is for the delivery of Zortress 1 mg tablets. This is a Firm Fixed Price Delivery Order contract type, with an ultimate completion date of February 4, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,592.83 firm fixed-price delivery order is for the supply of Zortress 0.25 mg tablet medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZORTRESS 0.25 MG TABLET UD 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,329.21 and a period of performance through February 12, 2025. The contract has no set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the drug Zortress (everolimus) 0.5 mg tablets. The $5,558.16 firm fixed-price delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Zortress (everolimus) 0.25 mg tablets. The award is a delivery order with a firm fixed price of $3,385.45 and an ultimate completion date of August 1, 2024. The contract does not have a set-aside designation. As a large Indefinite Delivery Contract (IDC) holder with the DLA, AmerisourceBergen is a key supplier of a wide range of...